NCT00537329 - Anidulafungin In Treatment Of Candidemia In Asian Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Candidemia

Interventions

DRUG

Anidulafungin

Eligible subjects will be initiated on a single loading dose of 200 mg IV anidulafungin, followed by 100 mg IV anidulafungin once daily for a minimum of 5 days but not more than 42 days.

Trial Locations (13)

100

Pfizer Investigational Site, Taipei

220

Pfizer Investigational Site, Banqiao District

404

Pfizer Investigational Site, Taichung

704

Pfizer Investigational Site, Tainan City

1200

Pfizer Investigational Site, Legaspi Village, Makati City

10330

Pfizer Investigational Site, Pathumwan

40002

Pfizer Investigational Site, Amphoe Mueang

50200

Pfizer Investigational Site, Amphoe Mueang

201301

Pfizer Investigational Site, Noida

560034

Pfizer Investigational Site, Bangalore

380 054

Pfizer Investigational Site, Ahmedabad

400 022

Pfizer Investigational Site, Mumbai

141 001

Pfizer Investigational Site, Ludhiana